Prosecution Insights
Last updated: October 25, 2026
Application No. 18/668,628

DEVICE FOR ADMINISTERING A FLUID PRODUCT

Non-Final OA §102§103
Filed
May 20, 2024
Priority
Feb 26, 2014 — continuation of PCTEP2014053668 +2 more
Examiner
SCHMIDT, EMILY LOUISE
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Mylife Diabetes Care AG
OA Round
1 (Non-Final)
58%
Grant Probability
Moderate
1-2
OA Rounds
11m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allowance Rate
595 granted / 1018 resolved
-11.6% vs TC avg
Strong +37% interview lift
Without
With
+36.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
57 currently pending
Career history
1098
Total Applications
across all art units

Statute-Specific Performance

§101
1.3%
-38.7% vs TC avg
§103
49.6%
+9.6% vs TC avg
§102
21.9%
-18.1% vs TC avg
§112
22.3%
-17.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1018 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-5 and 7-20 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kamen et al. (US 2011/0230837 A1). With regard to claim 1, Kamen et al. teach a medical infusion pump for administering a fluid product, comprising: a housing (Fig. 1A member 102); a drive device (Fig. 2 including at least 214, 228, 224); a product container (Fig. 2 member 222) compartment at least partly disposed in the housing and accessible through a product container compartment opening in an outer wall of the housing (Fig. 1C accessed through at least 112); and a battery compartment at least partly disposed in the housing and accessible through a battery compartment opening in the outer wall of the housing (Fig. 1C and 1D, compartment 118 accessed through 116), wherein the drive device is configured to be powered by a battery positioned in the battery compartment in a drive movement in which the fluid product is dispensed from a product container positioned in the product container compartment (Fig. 12H battery 1236, [0267]), wherein a battery compartment lid is configured to open and close the battery compartment opening (Figs. 1C and 12H lid including at least 116/12200), the battery compartment lid comprising a plastic part (shown in 12H but not numbered, see exemplary 12A 1026’, [0261]) and a metal cap (Fig. 12H 12204, [0266]), wherein the plastic part is electrically non-conductive ([0261]), wherein the metal cap includes a proximal surface facing the plastic part and a distal surface facing an interior of the battery compartment when the battery compartment lid closes the battery compartment (Fig. 112H distal face toward battery, proximal face toward lid), the metal cap comprising a plurality of through-holes extending from the proximal surface to the distal surface (Fig. 12H and Reference Figure 1 below, opposing holes on either side of 12204 and holes in surface attached to the lid), the plastic part comprising protrusions extending through through-holes of the metal cap, wherein the protrusions extend from the distal surface of the metal cap (Figs. 12E and Reference Figure 2 below) such that the protrusions form an arrangement in which a first terminal of a battery positioned in the battery compartment can contact the distal surface of the metal cap between the arrangement, resulting in an electrical contact between the metal cap and the first terminal, and in which a second terminal of the battery positioned in the battery compartment can contact the arrangement to prevent an electrical contact between the metal cap and the second terminal to thereby prevent reverse poling of the battery by reverse battery insertion into the battery compartment ([0267], arrangement is formed in conjunction with 12210, Fig. 12H). PNG media_image1.png 856 451 media_image1.png Greyscale PNG media_image2.png 570 525 media_image2.png Greyscale With regard to claims 2 and 3, see [0253]. With regard to claims 4 and 5, see at least [0261], [0267], Fig. 12H diameter of the terminal that fits in the lid is smaller to be received and the opposite end is larger and is not received. With regard to claim 7, see [0255]. With regard to claims 8 and 9, see Fig. 12H member 12216 ([0270]-[0271]). With regard to claim 10, Kamen et al. teach a medical infusion pump for administering a fluid product, comprising: a housing (Fig. 1A member 102); a drive device (Fig. 2 including at least 214, 228, 224); a product container (Fig. 2 member 222) compartment at least partly disposed in the housing and accessible through a product container compartment opening in an outer wall of the housing (Fig. 1C accessed through at least 112); and a battery compartment at least partly disposed in the housing and accessible through a battery compartment opening in the outer wall of the housing (Fig. 1C and 1D, compartment 118 accessed through 116), wherein the drive device is configured to be powered by a battery positioned in the battery compartment in a drive movement in which the fluid product is dispensed from a product container positioned in the product container compartment (Fig. 12H battery 1236, [0267]), wherein a battery compartment lid is configured to open and close the battery compartment opening (Figs. 1C and 12H lid including at least 116/12200), the battery compartment lid comprising a plastic part (shown in 12H but not numbered, see exemplary 12A 1026’, [0261]) and a metal cap (Fig. 12H 12204, [0266]), wherein the plastic part is electrically non-conductive ([0261]), wherein the metal cap includes a proximal surface facing the plastic part and a distal surface facing an interior of the battery compartment when the battery compartment lid closes the battery compartment (Fig. 112H distal face toward battery, proximal face toward lid), the metal cap comprising a plurality of through-holes extending from the proximal surface to the distal surface (Fig. 12H and Reference Figure 1 above, opposing holes on either side of 12204 and holes in surface attached to the lid), the plastic part comprising protrusions extending through through-holes of the metal cap, wherein the protrusions extend from the distal surface of the metal cap (Figs. 12E and Reference Figure 2 above) such that the protrusion form an arrangement configured to permit a first battery terminal to contact the distal surface of the metal cap between the arrangement, resulting in an electrical contact with the metal cap, and to cause a second battery terminal to contact the arrangement and prevent contact with the distal surface of the metal cap to thereby prevent the electrical contact ([0267], arrangement is formed in conjunction with 12210, Fig. 12H). With regard to claim 11, see [0255]. With regard to claim 12, see at least [0261], [0267], Fig. 12H diameter of the terminal that fits in the lid is smaller to be received and the opposite end is larger and is not received. With regard to claim 13, Kamen et al. teach a medical infusion pump for administering a fluid product, comprising: a housing (Fig. 1A member 102); a drive device (Fig. 2 including at least 214, 228, 224); a product container (Fig. 2 member 222) compartment at least partly disposed in the housing and accessible through a product container compartment opening in an outer wall of the housing (Fig. 1C accessed through at least 112); and a battery compartment at least partly disposed in the housing and accessible through a battery compartment opening in the outer wall of the housing (Fig. 1C and 1D, compartment 118 accessed through 116), wherein the drive device is configured to be powered by a battery positioned in the battery compartment in a drive movement in which the fluid product is dispensed from a product container positioned in the product container compartment (Fig. 12H battery 1236, [0267]), wherein a battery compartment lid is configured to open and close the battery compartment opening (Figs. 1C and 12H lid including at least 116/12200), the battery compartment lid comprising a plastic part (shown in 12H but not numbered, see exemplary 12A 1026’, [0261]) and a metal cap (Fig. 12H 12204, [0266]), wherein the plastic part is electrically non-conductive ([0261]), wherein the metal cap includes a proximal surface facing the plastic part and a distal surface facing an interior of the battery compartment when the battery compartment lid closes the battery compartment (Fig. 112H distal face toward battery, proximal face toward lid), the metal cap comprising a plurality of through-holes extending from the proximal surface to the distal surface (Fig. 12H and Reference Figure 1 above, opposing holes on either side of 12204 and holes in surface attached to the lid), the plastic part comprising protrusions extending through through-holes of the metal cap, wherein the protrusions extend past the distal surface of the metal cap (Figs. 12E and Reference Figure 2 above), such that the protrusions form a geometrical pattern which allows a first battery terminal to contact the distal surface of the metal cap but hinders direct contact of a second battery terminal to thereby prevent an electrical contact ([0267], pattern in conjunction with 12210 allows/hinders contact, Fig. 12H). With regard to claims 14 and 15, see [0253]. With regard to claims 16 and 17, see at least [0261], [0267], Fig. 12H diameter of the terminal that fits in the lid is smaller to be received and the opposite end is larger and is not received. With regard to claim 18, see [0255]. With regard to claims 19 and 20, see Fig. 12H member 12216 ([0270]-[0271]). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 6 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kamen et al. (US 2011/0230837 A1) as applied to claim 1 above, and further in view of Kelly, III et al. (US 4,101,818). With regard to claim 6, Kamen et al. teach a device substantially as claimed. Kamen et al. do not disclose the material of the metal to be nickel plated brass. However, Kelly, III et al. teach a suitable terminal contact material to be nickel plated brass (Col. 3 lines 48-52). It would have been obvious to a person having ordinary skill in the art before the effective filing date of the claimed invention to use nickel plated brass in Kamen et al. as Kelly, III et al. teach such is an effective conducting material which would yield the same predictable result of the battery providing power. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to EMILY L SCHMIDT whose telephone number is (571)270-3648. The examiner can normally be reached Monday through Thursday 7:00 AM to 4:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin Sirmons can be reached at 571-272-4965. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /EMILY L SCHMIDT/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

May 20, 2024
Application Filed
Oct 15, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12766264
NEEDLE-FREE INTRADERMAL INJECTION DEVICE
4y 12m to grant Granted Oct 20, 2026
Patent 12758747
NEUROSURGICAL APPARATUS AND METHODS
2y 8m to grant Granted Oct 13, 2026
Patent 12752059
INJECTION DEVICE AND A REUSABLE PART THEREFOR
4y 1m to grant Granted Oct 06, 2026
Patent 12741098
DEVICES AND METHODS FOR PRECISION DOSE DELIVERY
4y 2m to grant Granted Sep 22, 2026
Patent 12741123
SAFETY IV CATHETER WITH V-CLIP INTERLOCK AND NEEDLE TIP CAPTURE
3y 11m to grant Granted Sep 22, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
58%
Grant Probability
95%
With Interview (+36.6%)
3y 5m (~11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1018 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month